LIGAND PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ligand Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q3 2024.
  • Ligand Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending September 30, 2024 was $14.5M.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14.5M Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $14.5M Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $14M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $14M -$15.1M -51.7% Dec 31, 2023 10-Q 2024-11-08
Q4 2022 $29.1M -$454K -1.54% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $29.6M -$2.07M -6.54% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $31.6M +$2.97M +10.4% Dec 31, 2020 10-K 2024-02-29
Q4 2019 $28.6M -$1.64M -5.42% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $30.3M +$926K +3.15% Dec 31, 2018 10-K 2022-02-28
Q4 2017 $29.4M -$9.41M -24.3% Dec 31, 2017 10-K 2021-02-24
Q4 2016 $38.8M +$2.32M +6.36% Dec 31, 2016 10-K 2020-02-27
Q3 2016 $33.5M +$25.2M +304% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 $33.9M Jun 30, 2016 10-Q/A 2016-11-15
Q1 2016 $33.6M Mar 31, 2016 10-Q/A 2016-11-15
Q4 2015 $36.5M +$27.9M +328% Dec 31, 2015 10-K 2019-02-28
Q3 2015 $8.3M Sep 30, 2015 10-Q 2015-11-09
Q4 2014 $8.52M +$20K +0.24% Dec 31, 2014 10-K 2018-03-01
Q4 2013 $8.5M +$437K +5.42% Dec 31, 2013 10-K 2017-02-28
Q4 2012 $8.07M -$839K -9.42% Dec 31, 2012 10-K 2015-02-23
Q4 2011 $8.91M +$85K +0.96% Dec 31, 2011 10-K/A 2014-12-12
Q4 2010 $8.82M Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.